{"id":635504,"date":"2023-01-25T21:20:02","date_gmt":"2023-01-25T21:20:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=635504"},"modified":"2023-01-25T21:20:02","modified_gmt":"2023-01-25T21:20:02","slug":"scars-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/scars-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight_635504.html","title":{"rendered":"Scars Clinical Trials | A Drug Pipeline Analysis Report 2023 | DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1674623783.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Scars Clinical Trials | A Drug Pipeline Analysis Report 2023 | DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1674623783.jpeg\" alt=\"Scars Clinical Trials | A Drug Pipeline Analysis Report 2023 | DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Scars Pipeline Insights<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s, \u201cScars &#8211; Pipeline Insight, 2023,\u201d report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Scars pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.<\/div>\n<p style=\"text-align: justify;\">United States, Nevada, Las Vegas, DelveInsight&rsquo;s <strong>&#8216;<\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/scars-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\"><strong>Scars Pipeline Insight 2023<\/strong><\/a><strong>&#8216;<\/strong> report provides comprehensive global coverage of available, marketed, and pipeline Scars therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Scars pipeline domain.<\/p>\n<p style=\"text-align: justify;\"><strong>Key Takeaways from the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/scars-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">Scars Pipeline Report<\/a><\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Over 10+ Scars pipeline therapies are in various stages of development, and their anticipated acceptance in the Scars market would significantly increase market revenue.&nbsp;<\/li>\n<li>Leading Scars companies developing novel drug candidates to improve the Scars treatment landscape include<strong> First String Research, Sirnaomics, <\/strong>and others.<\/li>\n<li>Promising Scars pipeline therapies in various stages of development include<strong> Granexin Gel, STP 705, <\/strong>and others.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Scars Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">If the injury damages the top layer of the skin, patient likely sees new skin when the wound heals. To repair damage that goes deeper than the first layer, body makes a tissue that&rsquo;s thicker than skin. This thicker tissue often becomes a scar. New scars have a pink to reddish color. As a scar matures, it often turns lighter or darker than your skin. Most scars are flat, and the skin on top tends to look wrinkled. If body makes lots of extra tissue, a raised scar is seen. Sometimes, the body makes an excessive amount of extra tissue and a raised scar that is bigger than the original wound is seen. This type of raised scar is called a keloid. A sunken scar, is seen if something causes a lot of inflammation in skin, such as acne or chickenpox. This happens because the inflammation destroys collagen in the skin. This type of scar tends to appear when acne or chickenpox heals. With the right wound care, it&rsquo;s possible to minimize scarring. Sometimes, it can prevent a scar from forming. When caring for a wound, it&rsquo;s important to keep it clean. When cleaning a wound, use soap and water. Never use hydrogen peroxide, which can further damage the skin. It&rsquo;s also important to get stitches when patients need them. This can help the skin to heal and lessen scarring. Scars come in many shapes and sizes. If patient have two or more scars, patient may notice that the two scars look very different. This happens because so much affects what a scar looks like, including the: Cause (accident, acne, burn, surgery, etc.), wound (size and how deeply the wound penetrated your skin), body part (where you wounded your skin), wound care (how you treated the wound). A scar forms when the body heals an injury. When a person injure the skin, a scar can form after the wound heals.&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scars Pipeline Analysis: Drug Profile<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Granexin Gel : First String Research<\/strong><\/p>\n<p style=\"text-align: justify;\">Granexin gel is a topical formulation of aCT1 developed to address unmet clinical needs within the field of dermatology. FirstString&rsquo;s dermatology program is currently focused on three main areas: medical countermeasures, cutaneous scarring, and thermal burns. Currently the product is in Phase 2\/3 stage of development in reducing scar severity in surgical wounds following bilateral anchor incision breast surgery.<\/p>\n<p style=\"text-align: justify;\">Discover more about the emerging Scars drugs @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/scars-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\"><strong>Scars Treatment Drugs<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Scars Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>First String Research<\/li>\n<li>Sirnaomics<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Scars Pipeline Therapies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Granexin Gel<\/li>\n<li>STP 705<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Scars Pipeline Therapeutics Assessment<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>By development stage<\/strong><\/li>\n<li><strong>By product type<\/strong><\/li>\n<li><strong>By route of administration<\/strong><\/li>\n<li><strong>By molecule type<\/strong><\/li>\n<li><strong>By MOA type&nbsp;<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Scope of the Scars Pipeline Report&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Coverage<\/strong>:&nbsp;Global&nbsp;<\/li>\n<li><strong>Key Scars Companies<\/strong>: First String Research, Sirnaomics, and others<\/li>\n<li><strong>Key Scars Pipeline Therapies<\/strong>: Granexin Gel, STP 705, and others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Find out more about the Scars treatment options in development @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/scars-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\"><strong>Scars Clinical Trials<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. Overview<\/p>\n<p style=\"text-align: justify;\">4. Pipeline Therapeutics<\/p>\n<p style=\"text-align: justify;\">5. Late-Stage Products (Phase III)<\/p>\n<p style=\"text-align: justify;\">6. Mid-Stage Products (Phase&nbsp; II)<\/p>\n<p style=\"text-align: justify;\">7. Early Stage Products (Phase&nbsp; I\/II)<\/p>\n<p style=\"text-align: justify;\">8. Preclinical Stage Products<\/p>\n<p style=\"text-align: justify;\">9. Discovery Stage Products<\/p>\n<p style=\"text-align: justify;\">10. Therapeutic Assessment<\/p>\n<p style=\"text-align: justify;\">11. Inactive Products<\/p>\n<p style=\"text-align: justify;\">12. Collaborations Assessment- Licensing \/ Partnering \/ Funding<\/p>\n<p style=\"text-align: justify;\">13. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">14. Market Drivers and Barriers<\/p>\n<p style=\"text-align: justify;\">15. Appendix<\/p>\n<p style=\"text-align: justify;\">16. About DelveInsight<\/p>\n<p style=\"text-align: justify;\"><strong>Request for a sample report to know more about leading companies in the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/scars-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=kpr\" target=\"_blank\">scars pipeline domain<\/a>.<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kritika Rehani<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=scars-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=scars-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scars Pipeline Insights DelveInsight\u2019s, \u201cScars &#8211; Pipeline Insight, 2023,\u201d report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Scars pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/scars-clinical-trials-a-drug-pipeline-analysis-report-2023-delveinsight_635504.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-635504","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/635504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=635504"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/635504\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=635504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=635504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=635504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}